Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, February 14, 2024
PanTera, the Belgian joint venture created by IBA and SCK CEN to secure large-scale production of alpha-emitting radioisotopes, announced the signing of a capacity reservation agreement with Bayer for the supply of actinium-225 (225Ac) starting in ...
read more
Wednesday, January 06, 2021
Panthera’s clinical trial sites began dosing volunteers in the Phase III trial which will evaluate AstraZeneca’s long-acting antibody combination for the potential prevention of COVID-19.
read more
Panthera Biopartners has appointed Chris Dodd as Executive VP of Business Development – Oncology and CNS.
read more
Panthera is on track to have a network of sites open across the UK by the end of the year.
read more
Monday, November 04, 2019
Independent SMO Panthera Biopartners has opened its first clinical trials site in Preston, Lancashire, UK.
read more
Panthera is now undertaking Phase II, III and IV vaccine trials on behalf of its pharma and CRO clients across its growing network of sites in the UK.
read more
Thursday, August 27, 2020
Since launching its first site in Preston in North West England in 2019, Panthera has expanded its network of UK clinical trial sites with a new site in North London.
read more
Panthera and Rutherford Health have entered a collaboration to create a network of clinical trial sites for the development of new cancer treatments.
read more
PANTHERx has been selected by Otsuka distribute JYNARQUE, the only FDA-approved therapy for patients diagnosed with autosomal dominant polycystic kidney disease.
read more
PAO Group has previewed its next acquisition after closing the acquisition of a cannabis biopharmaceutical asset to treat COPD and a cannabis cultivation operation developing a proprietary cannabis cultivar.
read more
Tuesday, October 27, 2020
PAO Group has executed a master services agreement with a clinical research organization in the U.S. to prepare PAOG for initiating an IND with the FDA.
read more
Paradigm Clinical Research, with three dedicated research sites in California and Colorado, announced it has grown its executive leadership team, bringing on board Travis Milnes as chief financial officer (CFO) and Amy Henderson as head of clinical ...
read more
Paradigm Clinical Research opened a clinical research site in Littleton, Colorado, their fourth location. The new site location complements the company's long-standing site in Wheat Ridge, Colorado.
read more
Wednesday, March 20, 2024
Paradigm Clinical Research, a clinical research site business, announced the opening of its flagship clinic in San Diego, California, coinciding with the celebration of the company’s 15th anniversary.
read more
Paradigm Health announced the launch of a research collaboration with the FDA focused on advancing a new model to accelerate clinical trial execution and regulatory review.
read more